ARVO Insight: Where members turn for eye & vision community news.
View this e-mail online.
View the mobile version.
Key Links
ARVO Home Page
ARVO Foundation for Eye Research
ARVOJobs
ARVO Funding Guide
ARVO Member Directory
Events & Education
ARVO Annual Meeting
ARVO/ISIE
ARVO/ISOCB
Clinical Trials Education Series
Drug & Gene Delivery Conference
Journals
Investigative Ophthalmology
& Visual Science
Journal of Vision
Translational Vision Science & Technology
Print Forward to a Friend
Insight, March 5
 



Come early, learn more
ARVO is offering full- and half-day Education Courses on Saturday, May 5 before the start of the Annual Meeting. View the full listing.

Separate registration is required in advance for ARVO’s Education Courses; they are not included with Annual Meeting registration. The early bird registration rate ends on March 23. Register now.

 

Manage ARVO e-News
Search Back Issues

Powerful new animal model for retinal degeneration research
Researchers have created a genetically accurate RP-like condition in a mini-pig that could answer challenges posed by existing rodent and pig models.
Members in the news
Target of animal rights extremists awarded for courage

Dario Ringach, PhD, is honored by the American Association for the Advancement of Science for defending the use of animals in research.  

Everything ARVO
IM section members present young investigator awards

Two awards will honor best poster or paper presentations.
Application deadline: April 6

Get involved: Volunteer for an ARVO committee

Members are needed to fill vacancies on 10 different committees. Application deadline: March 16.

Community news
Travel awards available: NEI stem cells symposium

The one-day meeting will target advances in stem cells research as they relate to ocular physiology and disease analysis.

NSF reports on global spending trends
The National Science Foundation shares data on R&D performance.
Airlines ban transport of primates

Commercial airline restrictions impact global medical research.

Foundation news
Support WEAVR events in Fort Lauderdale

      •  Women in Eye and Vision Research (WEAVR) Luncheon
      •  WEAVR Silent Auction

Advocacy
Action requested

   •  Consumer perspectives for FDA advisory panels: Due March 14
   •  Ophthalmic drug and device experts: Due March 16
   •  Feedback on translation of cell based therapies: Due March 16
   •  Pharmaceutical regulatory project management training participants
   •  Feedback on safety data guidance for clinical trials  
   •  Information for rare disease patient database

ARVO Journals
IOVS

Special issue will highlight workshop findings on glaucoma treatment.

JOV

20 most-read articles in January

TVST

There is still time to submit your work for the premiere issue of Translational Vision Science & Technology.

ARVOJobs
Home to the best jobs in eye and vision research

Opportunities for faculty, postdocs and others!

Grants and awards
Funding opportunities

ARVO Funding Guide:

Academic Research Enhancement Award • NEI Regulatory Assistance Program • Clinical/Research Fellowship in Inherited Orphan Retinal Degenerations • Sigma Xi Grants-in-Aid of Research • EBAA • Health Care Systems Research Collaboratory Programs • Prevent Blindness America • New: Scholarships for laboratory animal science course • Lions Club • Research to Prevent Blindness • New: Visiting professorship

Awards

$50,000 Enrico Fermi Award: Deadline March 15
New: Raniyah Ramadan Award in microbiology • Cora Verhagen Prize in immunology




Association for Research in Vision and Ophthalmology
1801 Rockville Pike, Suite 400 | Rockville MD 20852-5622
tel: +1.240.221.2900 | fax: +1.240.221.0370 | arvo@arvo.org | www.arvo.org
You are receiving ARVO Insight as a member service or because of your involvement with ARVO.
If you do not wish to receive Insight, please unsubscribe.

View ARVO's Privacy Policy.

To ensure delivery of Insight, please add arvo@arvo.org to your e-mail address book or Safe Sender List.
If you are still having problems receiving our communications, get more information about white-listing.